Dongguan Zileman Health Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Dongguan Zileman Health Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include WALKONAIR. The owner is based in Guangdong Province.

Room 501, Building 10, No. 10,

Guangdong Province 523518 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WALKONAIR
WALKONAIR
Registered 2023

Trademark Classifications

Dongguan Zileman Health Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Dongguan Zileman Health Technology Co., Ltd. have?

Dongguan Zileman Health Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Dongguan Zileman Health Technology Co., Ltd. file in?

Dongguan Zileman Health Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Dongguan Zileman Health Technology Co., Ltd.'s most well-known trademarks?

Dongguan Zileman Health Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as WALKONAIR. These are among 1 currently registered trademark in the portfolio.

What is Dongguan Zileman Health Technology Co., Ltd.'s trademark registration success rate?

Dongguan Zileman Health Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.